Press Releases

Varian Becomes First Medical Technology Company Joining the Cancer Drug Development Forum

Varian (NYSE: VAR) announced it has joined the Cancer Drug Development Forum (CDDF) as an industry partner. This makes Varian the first medical technology company to join CDDF, the leading...

Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health

Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger...

Varian Reports Results for First Quarter of Fiscal Year 2021

First Quarter 2021 Summary Oncology Systems gross orders grew 2% in dollars or 1% in constant currency in the quarter; trailing twelve months gross orders down 5% in dollars or 6% in constant currency

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in all nine of the tracked categories. Additionally,...

Varian Announces First Quarter Fiscal Year 2021 Earnings Release Date

Varian (NYSE: VAR) today announced its first quarter fiscal year 2021 earnings release date. The Company will report results for the first quarter of fiscal year 2021 after market close on...

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer

Varian (NYSE: VAR) and the Cincinnati Children's/UC Health Proton Therapy Center today announce the start of the first clinical trial of FLASH therapy as part of the recently opened FAST-01 study...

Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care

Varian (NYSE: VAR) today announced a new $10M investment and collaboration agreement with COTA, Inc., a Boston-based curator of clinical data in oncology. Both companies will work together to...

Varian Reports Results for Fourth Quarter of Fiscal Year 2020

Fourth Quarter 2020 Summary Oncology Systems gross orders of $1.0 billion, down 8% in dollars or 10% in constant currency 10 Ethos™ orders received, including 5 in North America and 5 in EMEA...

Varian Congratulates Historic Trade Package Agreement with Brazil

Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement...

Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care™

Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care™ during the 2020 American Society...